Impact of loperamide on the pharmacokinetics and tissue disposition of ritonavir-boosted oral docetaxel therapy; a preclinical assessment
Author:
Publisher
Springer Science and Business Media LLC
Link
https://link.springer.com/content/pdf/10.1007/s00280-024-04662-8.pdf
Reference20 articles.
1. Yared JA, Tkaczuk KH (2012) Update on taxane development: new analogs and new formulations. Drug Des Devel Ther 6:371–384
2. Hendrikx JJ et al (2014) Oral co-administration of elacridar and ritonavir enhances plasma levels of oral paclitaxel and docetaxel without affecting relative brain accumulation. Br J Cancer 110(11):2669–2676
3. Loos NHC et al (2023) Enhancement of the oral availability of Cabazitaxel using the cytochrome P450 3A (CYP3A) inhibitor ritonavir in mice. Mol Pharm 20(5):2477–2489
4. de Weger VA et al (2021) A phase 1 dose-escalation study of low-dose metronomic treatment with novel oral paclitaxel formulations in Combination with Ritonavir in patients with Advanced Solid tumors. Clin Pharmacol Drug Dev 10(6):607–621
5. Vermunt M, Marchetti S, Beijnen J (2021) Pharmacokinetics and toxicities of oral docetaxel formulations co-administered with Ritonavir in Phase I trials. Clin Pharmacol 13:21–32
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3